FAQs
2656 State Street, Carlsbad CA 92008
Tyra Biosciences is incorporated in Delaware.
Tyra Biosciences was founded in 2018.
Tyra Biosciences’ shares are traded on the Nasdaq Global Market under the symbol “TYRA”.
Tyra went public on September 14, 2021.
Tyra Biosciences’ fiscal year ends on December 31.
Ernst & Young LLP
Latham & Watkins LLP
12670 High Bluff Drive
San Diego, California 92130
Shares of Tyra Biosciences’ stock can be purchased by contacting a securities broker of your choice.
No. Tyra does not have a direct stock purchase plan. You may purchase shares of Tyra through a broker of your choice.
Computershare Trust Company, N.A
For questions about your stock, please contact our transfer agent, Computershare Trust Company, N.A., 150 Royall Street, Suite 101, Canton, MA 02021 or P.O. Box 43006, Providence, RI 02940-3006.
Quarterly & Annual reports and other investor materials are available in the “Investors” section of Tyra Biosciences’ corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
- Please click here to be directed to the email alerts page.
For media and investor inquiries, please send an email to aconrad@tyra.bio.